Genetic polymorphisms of CYP2C19 and effect of CYP2C19☆2 allele on clopidogrel P2Y12 inhibition in healthy Malaysian volunteers

被引：0
|
作者：
Sani, Y. N. [1 ]
Lim, S. C. [1 ]
Lim, L. H. [1 ]
Edwin, N. E. Y. [1 ]
Khan, N. Abdul Karim [1 ]
Goh, T. H. [2 ]
Serebruany, V. L. [3 ]
Yuen, K. H. [1 ]
机构：
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Loh Guan Lye Specialists Ctr, George Town, Malaysia
[3] Johns Hopkins Univ, Towson, MD USA
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：874 / 874
页数：1
相关论文
共 50 条
  • [1] The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19☆2 genotyping
    Langaee, Taimour Y.
    Zhu, Hao-Jie
    Wang, Xinwen
    El Rouby, Nihal
    Markowitz, John S.
    Goldstein, Joyce A.
    Johnson, Julie A.
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (08): : 381 - 386
  • [2] The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients
    Namazi, Soha
    Kojuri, Javad
    Khalili, Andia
    Azarpira, Negar
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (07) : 903 - 908
  • [3] Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole
    Zalloum, Imad
    Hakooz, Nancy
    Arafat, Tawfiq
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (04) : 4195 - 4200
  • [4] Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole
    Imad Zalloum
    Nancy Hakooz
    Tawfiq Arafat
    Molecular Biology Reports, 2012, 39 : 4195 - 4200
  • [5] Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes
    Tu, J. -H.
    Hu, D. -L.
    Dai, L. -L.
    Sun, Y.
    Fan, L.
    Zhang, M.
    Tan, Z. -R.
    Chen, Y.
    Li, Z.
    Zhou, H. -H.
    XENOBIOTICA, 2010, 40 (06) : 393 - 399
  • [6] Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles
    Kim, K. -A.
    Song, W. -K.
    Kim, K. -R.
    Park, J. -Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (06) : 697 - 703
  • [7] Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel
    Malek, Lukasz A.
    Kisiel, Bartlomiej
    Spiewak, Mateusz
    Grabowski, Marcin
    Filipiak, Krzysztof J.
    Kostrzewa, Grazyna
    Huczek, Zenon
    Ploski, Rafal
    Opolski, Grzegorz
    CIRCULATION JOURNAL, 2008, 72 (07) : 1165 - 1169
  • [8] Evaluation of CYP2C19, P2Y12, and ABCB1 polymorphisms and phenotypic response to clopidogrel in healthy Indian adults
    Sridharan, Kannan
    Kataria, Rachna
    Tolani, Drishti
    Bendkhale, Shital
    Gogtay, Nithya J.
    Thatte, Urmila M.
    INDIAN JOURNAL OF PHARMACOLOGY, 2016, 48 (04) : 350 - 354
  • [9] Dual P2Y12 and CYP2C19 gene polymorphism as a better marker of clopidogrel resistence
    Malek, L. A.
    Kisiel, B.
    Spiewak, M.
    Filipiak, K. J.
    Grabowski, M.
    Kostrzewa, G.
    Ploski, R.
    Opolski, G.
    EUROPEAN HEART JOURNAL, 2007, 28 : 126 - 127
  • [10] The CYP2C19 *1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
    Sani, Yanti Nasyuhana
    Chin, Lim Sheau
    Hui, Lim Luen
    Edwin, Nur Elyana Yazmin Mohd Redhuan Shah
    Hwa, Goh Teck
    Serebruany, Victor L.
    Hay, Yuen Kah
    CARDIOLOGY RESEARCH AND PRACTICE, 2013, 2013
12345